Top Markets
Coin of the day
Verici Dx plc Verici Dx plc

Verici Dx plc

VRCI
Rangering i aksjer #40975
Verici Dx plc is an immuno-diagnostics company primarily focused on the kidney... Verici Dx plc is an immuno-diagnostics company primarily focused on the kidney transplantation sector. The firm specializes in creating both predictive and diagnostic assays for patients who have undergone kidney transplants. Its development pipeline features Clarava, a pre-transplant tool designed to forecast the likelihood of early acute rejection; Tuteva, a post-transplant assessment focusing on acute cellular rejection; and Protega, an innovative liquid biopsy aiming to predict the risk of fibrosis and eventual graft failure. Established in 2020, Verici Dx plc maintains its headquarters in Penarth, United Kingdom.
Aksjekurs
$0.00338543
Markedsverdi
$56.59K
Endring (1 dag)
-0.48%
Endring (1 år)
-52.51%
Land
GB
Handel Verici Dx plc (VRCI)

Kategori

Utbyttehistorikk for Verici Dx plc (VRCI)
Verici Dx plc (aksjesymbol: VRCI) har gitt totalt 0 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): 0.00
Utbytteavkastning (TTM): 0
Utbyttebetalinger for Verici Dx plc (VRCI) fra 2026 til 2026
Årlige utbyttebetalinger
År Utbytte (justert for aksjesplitt) Endre
Ikke nok data for de angitte datoene.
Liste over alle utbyttebetalinger
År Utbytte Endre
Ikke nok data for de angitte datoene.
Utbyttebetalinger for lignende selskaper eller konkurrenter